Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

NCT00003786 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped NO participants

Conditions

Colorectal Cancer

Interventions

DRUG: irofulven

Sponsor

University of Chicago

Collaborators

[object Object]